Arm lymphoedema in a cohort of breast cancer survivors 10 years after diagnosis
- PMID: 20100154
- DOI: 10.3109/02841860903483676
Arm lymphoedema in a cohort of breast cancer survivors 10 years after diagnosis
Abstract
Introduction: Arm lymphoedema is a frequent complication after breast cancer treatment. Early diagnosis and treatment is considered important for successful management of breast cancer related arm lymphoedema (BCRL). The purpose was to identify BCRL incidence, time of onset, progression/regression and associated factors 10 years after breast cancer diagnosis.
Material and methods: Two hundred and ninety two patients treated with axillary node dissection and radiotherapy were included in this retrospective study. A total of 111 diagnosed with BCRL (incidence 38.7%). Of these women 98 were followed for up to 10 years after BCRL diagnosis. Forty consecutive patients registered with no BCRL were included in the control group. BCRL was defined as an increase in arm volume difference >or=5% and an increased thickness of subcutis. Follow-up was performed twice a year, including assessment of lymphoedema relative volume (LRV) by water displacement method and compression treatment. Additional intensive treatment was given if LRV increased by more than 5% since the previous visit or exceeded 20% in total.
Results: Mean LRV was 8.1 +/-3.6% at diagnosis and 9.0+/-6.7% at last follow-up measurement (mean 48.9+/-39.2 months) with no significant difference. There was no difference in progression of LRV between groups with early versus late diagnosis (within or after 12 months postoperatively), small (5-<10%) versus large (>or=10%) LRV at time of diagnosis, or regular (at least twice a year) versus non-regular treatment. More BCRL patients with large LRV at diagnosis (15.8%), exceeded LRV >or=20% during follow-up time, than patients with small LRV at diagnosis (10.1%).
Conclusion: BCRL can be identified at an early stage both in regard to time of diagnosis after operation and to edema volume, and that edema volume can be kept at a low level for at least 10 years. Small LRV at time of diagnosis appears to be more important for minimizing the progression of LRV than time of diagnosis after operation.
Similar articles
-
Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study.J Clin Oncol. 2009 Apr 20;27(12):2007-14. doi: 10.1200/JCO.2008.18.3517. Epub 2009 Mar 16. J Clin Oncol. 2009. PMID: 19289624
-
Lymphedema following breast cancer treatment, including sentinel lymph node biopsy.Lymphology. 2004 Jun;37(2):73-91. Lymphology. 2004. PMID: 15328760
-
Prevalence of lymphoedema more than five years after breast cancer treatment.Eur J Surg Oncol. 2011 Dec;37(12):1059-63. doi: 10.1016/j.ejso.2011.09.001. Epub 2011 Sep 19. Eur J Surg Oncol. 2011. PMID: 21937192
-
Breast cancer-related lymphoedema risk reduction advice: a challenge for health professionals.Cancer Treat Rev. 2008 Nov;34(7):621-8. doi: 10.1016/j.ctrv.2007.11.002. Epub 2008 Aug 8. Cancer Treat Rev. 2008. PMID: 18691823 Review.
-
Lymphedema following axillary lymph node dissection for breast cancer.Surg Oncol. 2006 Nov;15(3):153-65. doi: 10.1016/j.suronc.2006.11.003. Epub 2006 Dec 21. Surg Oncol. 2006. PMID: 17187979 Review.
Cited by
-
Estimation of Neural Tissue Mobility in Breast Cancer Survivors with Lymphedema.Asian Pac J Cancer Prev. 2022 Oct 1;23(10):3355-3360. doi: 10.31557/APJCP.2022.23.10.3355. Asian Pac J Cancer Prev. 2022. PMID: 36308359 Free PMC article.
-
Lymphatic remapping by long-term lymphoscintigraphy follow-up in secondary lymphedema after breast cancer surgery.Sci Rep. 2024 Jan 6;14(1):728. doi: 10.1038/s41598-023-50558-7. Sci Rep. 2024. PMID: 38184673 Free PMC article.
-
The impact of early detection and intervention of breast cancer-related lymphedema: a systematic review.Cancer Med. 2016 Jun;5(6):1154-62. doi: 10.1002/cam4.691. Epub 2016 Mar 19. Cancer Med. 2016. PMID: 26993371 Free PMC article.
-
Implementing a prospective surveillance and early intervention model of care for breast cancer-related lymphedema into clinical practice: application of the RE-AIM framework.Support Care Cancer. 2021 Feb;29(2):1081-1089. doi: 10.1007/s00520-020-05597-5. Epub 2020 Jun 29. Support Care Cancer. 2021. PMID: 32613370 Free PMC article.
-
Life after breast cancer: moving on, sitting down or standing still? A prospective study of Canadian breast cancer survivors.BMJ Open. 2018 Jul 28;8(7):e021770. doi: 10.1136/bmjopen-2018-021770. BMJ Open. 2018. PMID: 30056387 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical